Colgate-Palmolive Company

Colgate-Palmolive Company

CLยทNYSE

$84.87

-4.0%
Consumer DefensiveHousehold & Personal Products

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

At a Glance

Live Snapshot
Market Cap$67.91B
EPS2.6400
P/E Ratio32.15
Earnings Date07/31/2026
3Y+4.0%
5Y+3.0%
10Y+35.0%
3Y+7.0%
5Y+8.0%
10Y+32.0%
3Y-55.0%
5Y-67.0%
10Y+2047.0%
cl

Colgate-Palmolive Company Funding & Solvency Profile

CL ยท NYSE
Cash & Cash Equivalents1.29B
Net Receivables1.68B
Inventory2.03B
Other Current Assets714.00M
Total Current Assets6 B
Property, Plant & Equipment4.66B
Goodwill & Intangible Assets4.66B
Long-Term Investments0.00
Other Non-Current Assets1.30B
Total Non-Current Assets6 B
Total Assets
16.33B

Financial Health Analysis

Current Ratio

1.00x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

43.74x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

-27000000

Negative working capital indicates short-term liabilities exceed short-term assetsโ€”potential liquidity stress.

Asset Composition

35% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

Colgate-Palmolive Company Balance Sheet

CL โ€ข NYSE

Colgate-Palmolive Company Balance SheetDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009Dec 2008Dec 2007Dec 2006
ASSETS
CURRENT ASSETS
1.3B
1.1B
966M
775M
832M
888M
883M
726M
1.5B
1.3B
970M
1.1B
962M
884M
878M
490M
600M
554.9M
428.7M
489.5M
0.0
160M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.3B
1.3B
966M
775M
832M
888M
883M
726M
1.5B
1.3B
970M
1.1B
962M
884M
878M
490M
600M
555M
428.7M
489.5M
1.7B
1.5B
1.6B
1.5B
1.3B
1.3B
1.4B
1.4B
1.5B
1.4B
1.4B
1.6B
1.6B
1.7B
1.7B
1.6B
1.6B
1.6B
1.7B
1.5B
1.7B
1.5B
1.6B
1.5B
1.3B
1.3B
1.4B
1.4B
1.5B
1.4B
1.4B
1.6B
1.6B
1.7B
1.7B
1.6B
1.6B
1.6B
1.7B
1.5B
2B
2B
1.9B
2.1B
1.7B
1.7B
1.4B
1.3B
1.2B
1.2B
1.2B
1.4B
1.4B
1.4B
1.3B
1.2B
1.2B
1.2B
1.2B
1B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-12.2M
0.0
0.0
714M
553M
793M
760M
576M
513M
456M
417M
403M
441M
807M
840M
799M
639M
522M
408M
375M
366.1M
338.1M
279.9M
5.7B
5.3B
5.3B
5.1B
4.4B
4.3B
4.2B
3.8B
4.6B
4.3B
4.4B
4.9B
4.8B
4.6B
4.4B
3.7B
3.8B
3.7B
3.6B
3.3B
NON-CURRENT ASSETS
4.7B
4.4B
4.6B
4.3B
3.7B
3.7B
3.8B
3.9B
4.1B
3.8B
3.8B
4.1B
4.1B
3.8B
3.7B
3.7B
3.5B
3.1B
3B
2.7B
3.1B
3.3B
3.4B
3.4B
3.3B
3.8B
3.5B
2.5B
2.2B
2.1B
2.1B
2.3B
2.5B
2.5B
2.7B
2.4B
2.3B
2.2B
2.3B
2.1B
1.5B
1.8B
1.9B
1.9B
2.5B
2.9B
2.7B
1.6B
1.3B
1.3B
1.3B
1.4B
1.5B
1.5B
1.3B
831M
821M
833.5M
844.8M
831.1M
4.7B
5B
5.3B
5.3B
5.7B
6.7B
6.2B
4.2B
3.6B
3.4B
3.4B
3.7B
4B
4B
4B
3.7B
3.8B
3.1B
3.1B
2.9B
0.0
81M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
195M
214M
135M
193M
291M
177M
152M
188M
301M
67M
76M
77M
92M
115M
108M
82M
81.9M
264.1M
309.9M
1.3B
1B
1B
904M
974M
857M
753M
168M
218M
224M
239M
720M
924M
905M
541M
556M
685M
164M
361.5M
228M
10.6B
10.7B
11.1B
10.6B
10.6B
11.6B
10.9B
8.4B
8B
7.8B
7.6B
8.6B
9.1B
8.8B
8.3B
7.4B
7.3B
6.3B
6.5B
5.8B
16.3B
16B
16.4B
15.7B
15B
15.9B
15B
12.2B
12.7B
12.1B
12B
13.5B
13.9B
13.4B
12.7B
11.2B
11.1B
10B
10.1B
9.1B
LIABILITIES
CURRENT LIABILITIES
0.0
2.8B
2.2B
2B
2B
1.9B
1.7B
1.8B
1.7B
1.7B
1.5B
1.6B
1.7B
1.6B
1.7B
1.4B
1.6B
1.3B
1.1B
1B
0.0
1.8B
1.7B
1.6B
1.5B
1.4B
1.2B
1.2B
1.2B
1.1B
1.1B
1.2B
1.3B
1.3B
1.2B
1.2B
1.2B
1.1B
1.1B
1B
0.0
973M
503M
450M
554M
519M
474M
538M
477M
553M
398M
416M
370M
302M
427M
272M
387M
272M
0.0
0.0
0.0
2.1B
2B
1.8B
1.7B
1.9B
1.6B
1.5B
1.6B
1.5B
1.6B
1.7B
1.9B
1.7B
1.6B
1.7B
1.7B
1.4B
1.8B
1.5B
0.0
660M
330M
25M
51M
267M
514M
12M
11M
13M
302M
504M
908M
304M
380M
609M
361M
198M
294M
950.8M
0.0
107M
95M
108M
137M
137M
145M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
565M
503M
450M
554M
519M
474M
538M
477M
553M
398M
416M
261M
302M
392M
272M
387M
272.4M
262.7M
161.5M
5.7B
116M
122M
97M
93M
182M
70M
93M
101M
84M
79M
94M
105M
96M
90M
0.0
0.0
0.0
0.0
0.0
5.7B
5.8B
4.7B
4B
4.1B
4.4B
4B
3.3B
3.4B
3.3B
3.5B
3.9B
4.6B
3.7B
3.7B
3.7B
3.6B
3B
3.2B
3.5B
NON-CURRENT LIABILITIES
8B
7.3B
8.2B
8.7B
7.2B
7.3B
7.3B
6.4B
6.6B
6.5B
6.2B
5.6B
4.7B
4.9B
4.4B
2.8B
2.8B
3.6B
3.2B
2.7B
0.0
343M
361M
383M
395M
426M
507M
235M
204M
246M
233M
261M
444M
293M
252M
108M
82M
81.9M
264.1M
309.9M
2.2B
1.7B
1.7B
1.4B
2B
2.2B
2.1B
2B
2.3B
2B
2B
2.2B
1.7B
2B
1.8B
1.7B
1.4B
1.5B
1.1B
1.2B
10.2B
9.7B
10.7B
10.9B
10B
10.4B
10.4B
8.6B
9B
8.8B
8.4B
8.1B
6.9B
7.3B
6.5B
4.6B
4.3B
5B
4.6B
4.3B
0.0
563M
515M
505M
588M
613M
636M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
16B
15.5B
15.4B
14.9B
14.1B
14.8B
14.5B
12B
12.4B
12.1B
12B
12.1B
11.3B
11B
10.2B
8.4B
7.9B
8.1B
7.7B
7.7B
SHAREHOLDERS' EQUITY
0.0
-27.4B
-26B
-25.1B
-24.1B
-23B
-22.1B
-21.2B
-20.2B
-19.1B
-18.1B
-16.9B
-15.6B
-14.4B
-12.8B
-11.3B
-10.5B
-9.7B
-8.9B
-8.1B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
169M
181M
197.5M
222.7M
0.0
1.5B
1.5B
1.5B
1.5B
1.5B
1.5B
1.5B
1.5B
1.5B
1.5B
1.5B
1.5B
733M
733M
733M
733M
732.9M
732.9M
732.9M
0.0
4.2B
3.8B
3.5B
3.3B
3B
2.5B
2.2B
2B
1.7B
1.4B
1.2B
1B
1.6B
1.3B
1.1B
1.8B
1.6B
1.5B
1.2B
0.0
26.1B
25.3B
24.6B
24.4B
23.7B
22.5B
21.6B
20.5B
19.9B
18.9B
18.8B
18B
17B
15.6B
14.3B
13.2B
11.8B
10.6B
9.6B
0.0
-4.2B
-3.9B
-4.1B
-4.4B
-4.3B
-4.3B
-4.2B
-3.9B
-4.2B
-4B
-3.5B
-2.5B
-2.6B
-2.5B
-2.1B
-2.1B
-2.5B
-1.9B
-2.3B
54M
0.0
0.0
-1M
-1M
-1M
-2M
-3M
-5M
-7M
-12M
-20M
-33M
-41M
-60M
-99M
-133M
600K
0.0
0.0
54M
212M
609M
401M
609M
743M
117M
-102M
-60M
-243M
-299M
1.1B
2.3B
2.2B
2.4B
2.7B
3.1B
1.9B
2.3B
1.4B
365M
544M
957M
806M
971M
1.1B
558M
197M
243M
17M
-44M
1.4B
2.5B
2.4B
2.5B
2.8B
3.3B
1.9B
2.4B
1.4B
311M
332M
348M
405M
362M
358M
441M
299M
303M
260M
255M
240M
231M
201M
166M
142M
141M
0.0
109.9M
0.0
SUMMARY
16.3B
16B
16.4B
15.7B
15B
15.9B
15B
12.2B
12.7B
12.1B
12B
13.5B
13.9B
13.4B
12.7B
11.2B
11.1B
10B
10.1B
9.1B
0.0
241M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
8B
8.5B
9.1B
9.3B
7.8B
8.2B
8.5B
6.4B
6.6B
6.5B
6.5B
6.1B
5.7B
5.2B
4.8B
3.4B
3.2B
3.8B
3.5B
3.7B
6.7B
7.4B
8.1B
8.5B
7B
7.3B
7.6B
5.6B
5B
5.2B
5.6B
5.1B
4.7B
4.3B
3.9B
2.9B
2.6B
3.2B
3.1B
3.2B
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625
806,133,625

SEC Filings

CL - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 13, 2026
May 08, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 01, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 01, 2026
April 30, 2026
2026
8-K

8-K 2026

N/A

April 09, 2026
April 08, 2026
2026
DEF 14A

DEF 14A 2026

N/A

March 25, 2026
May 08, 2026
2026
8-K

8-K 2026

N/A

March 17, 2026
March 17, 2026
2026
8-K

8-K 2026

N/A

March 12, 2026
March 12, 2026
2026
10-K

10-K 2025 FY

FY

February 23, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

January 30, 2026
January 30, 2026
2026
8-K

8-K 2025

N/A

November 10, 2025
November 03, 2025
2025
Showing 1 to 10 of 393 filings